• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Zhao Songji  趙 松吉

… Alternative Names

ZHAO CHOKICHI  趙 松吉

Less
Researcher Number 80374239
Other IDs
  • ORCIDhttps://orcid.org/0000-0002-5846-2326
External Links
Affiliation (Current) 2025: 福島県立医科大学, 公私立大学の部局等, 教授
Affiliation (based on the past Project Information) *help 2016 – 2025: 福島県立医科大学, 公私立大学の部局等, 教授
2017: 福島県立医科大学, ふくしま国際医療科学センター, 教授
2016: 福島県立医科大学, 福島国際医療科学センター, 教授
2015: 北海道大学, 医学研究科, 特任教授
2014 – 2015: 北海道大学, 医学(系)研究科(研究院), 特任教授 … More
2011 – 2015: 北海道大学, 医学(系)研究科(研究院), 教授
2014: 北海道大学, 大学院医学研究科, 特任教授
2012: 北海道大学, 大学院・医学研究科, 教授
2009 – 2010: 北海道大学, 大学院・医学研究科, 准教授
2008: 北海道大学, 大学院・医学研究科トレーサー情報学講座, 准教授
2007: 北海道大学, 大学院・医学研究科, 特任助教 Less
Review Section/Research Field
Principal Investigator
Basic Section 52040:Radiological sciences-related / Radiation science
Except Principal Investigator
Basic Section 52040:Radiological sciences-related / Radiation science / Basic Section 57060:Surgical dentistry-related
Keywords
Principal Investigator
白血病幹細胞 / ヒト化白血病モデルマウス / 抗CD82抗体 / α線放出核種 / 抗CDX抗体 / アスタチン-211標識抗体 / 標的アルファ線治療 / 急性骨髄性白血病 / RI内用療法 / 抗CD82抗体α線標的治療 … More / 抗hCD82ヒト化キメラmAb / 急性白血病 / アルファ線標的治療 / CD82抗原 / アスタチン-211 / プレターゲティング法 / アルファ線標的治療(TAT) / 白血病韓細胞 / アスタチン標識抗体 / 5-フルオロウラシル / PET/SPECT / IIMU / がんの核医学的分子イメージング / 5-FUプロドラッグ / 5-フルオロウラシル(5-FU) / 担癌モデル動物 / 抗がん剤Paclitaxel / プロドラッグ / 5-フルオロウラシル(5-FU) / SPECTイメージング / 核医学診断薬 / ヨウ素標識IIMU / チミジンホスホリラーゼ(TP) / SPECT / PET / SPECT/CT / PET/CT / 血管新生 / 細胞増殖 / がんの分子標的療法 / がん分子イメージング … More
Except Principal Investigator
チミジンホスホリラーゼ / 核医学治療 / 癌 / アスタチン / 核医学診断 / 放射線 / アスタチン211 / At-211 / α線 / PET / PSMA / アスタチン-211 / 治療用放射性薬剤 / 低酸素 / がん幹細胞 / CXCR4 / 211At / 放射性薬剤 / 5-フルオロウラシル / 治療効果予測 / 核医学 / 組織因子 / 不安定プラーク / 分子イメージング / 動脈硬化 / SNARE proteins / targeted α therapy / 前立腺癌 / 唾液腺 / radionuclide therapy / xerostomia / prostate cancer / salivary gland / radiation sialadenitis / 211At-PSMA / aargeted α therapy / CD82 / ドジメトリー / アビジン / ビオチン / アイソトープ治療 / プレターゲティング / 核医学(PET) / 核医学(PET) / 核医学(PET) / 動物モデル / 臨床研究 / 治療抵抗性 / FMISO-PET / FMISO / 頭頸部がん / 口腔がん / 遺伝子応答 / 二動原体染色体解析 / CXCL12 / 二次発癌 / 線量評価 / 急性白血病 / 染色体異常 / 標的α線治療 / 二次がん / アルファ線 / がん / トランスポーター / 個別化医療 / 有機カチオントランスポーター / イメージング剤 / がん治療効果予測 / 低酸素イメージング / 治療戦略 / 治療開発 / 再酸素化 / 治療効果 / 抗腫瘍効果 / エリブリン / 低酸素改善 / 化学療法 / 放射線治療 / Lu-177 / 標的RI治療 / 標的アイソトープ治療 / CXCX4 / 癌幹細胞 / 放射免疫療法 / 膵癌 / RI内用療法 / 自動合成 / 血管新生 / 放射性診断薬剤 / SPECT / 腫瘍 / 人工抗体 / ドキシフルリジン / カペシタビン / 抗がん剤 / イメージング / 臨床 / 生体分子 / ポジトロン断層撮影法 / 冠危険因子 / 心筋血流 / 血管内皮機能 Less
  • Research Projects

    (22 results)
  • Research Products

    (187 results)
  • Co-Researchers

    (54 People)
  •  68Ga-PSMA PETのdosimetryによる211At-PSMA治療後の唾液腺障害予測

    • Principal Investigator
      岡本 祥三
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  アスタチンー211標識ヒト・キメラCD82抗体による難治白血病に対する治療法の開発

    • Principal Investigator
      池添 隆之
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Elucidation of salivary gland uptake mechanisms and therapy application of 211At-PSMA ligand

    • Principal Investigator
      織内 昇
    • Project Period (FY)
      2024 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  薬物送達システムとα線放出核種を組み合わせた革新的な白血病治療法の開発Principal Investigator

    • Principal Investigator
      趙 松吉
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Development of novel At-211 labeled therapeutic radiopharmaceuticals targeting the angiogenic factor PD-ECGF

    • Principal Investigator
      NISHIJIMA Ken-ichi
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Optimization of pretargeted alpha therapy for multiple types of cancer

    • Principal Investigator
      Washiyama Kohshin
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Development of an innovative leukemia therapy using alpha-particle-emitting nuclides targeting cancer stem cellsPrincipal Investigator

    • Principal Investigator
      ZHAO Songji
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Development of thymidine phosphorylase imaging techniques precisely targeted to the tumor for personalized medicine

    • Principal Investigator
      Akizawa Hiromichi
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Showa Pharmaceutical University
  •  PD-ECGF targeted tumor treatment with new At-211 radiolabeled uracil derivatives

    • Principal Investigator
      NISHIJIMA Ken-ichi
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Analyses of chromosomal abnormality in normal somatic cells induced by alpha-particle therapy

    • Principal Investigator
      Oriuchi Noboru
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
  •  Novel strategy for treatment of oral cancer based on hypoxia imaging

    • Principal Investigator
      KITAGAWA Yoshimasa
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 57060:Surgical dentistry-related
    • Research Institution
      Hokkaido University
  •  Development of new therapeutic strategies for hypoxic tumors

    • Principal Investigator
      Shiga Tohru
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Fukushima Medical University
      Hokkaido University
  •  Prediction of response to anticancer therapy by thymidine phosphorylase imaging: pre-clinical proof of conceptPrincipal Investigator

    • Principal Investigator
      Zhao Songji
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Fukushima Medical University
  •  Development of alpha-particle therapy for pancreas cancer with stem cell-targeting 211At-labeled antibody

    • Principal Investigator
      Oriuchi Noboru
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Radiation science
    • Research Institution
      Fukushima Medical University
  •  Usefulness of imaging tumor-specific enzyme expression by radiopharmaceuticals with thymidine phosphorylase inhibitory potency

    • Principal Investigator
      Ohkua Kazue
    • Project Period (FY)
      2014 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Health Sciences University of Hokkaido
  •  PD-ECDF-targeted tumor imaging: Development of production system for I-123 labeled compound

    • Principal Investigator
      Nishijima Ken-ichi
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University
  •  Prediction of efficacy of anticancer agents by in vivo imaging of thymidine phosphorylase

    • Principal Investigator
      AKIZAWA Hiromichi
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Showa Pharmaceutical University
  •  Specific imaging of vulnerable atherosclerotic plaque: development of a novel SPECT probe using low molecular artificial antibody

    • Principal Investigator
      KUGE YUJI
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University
  •  Molecular imaging in tumor proliferation and angiogenesis: Development of a early assessment tool for measuring the tumor response to treatment with molecular targeted drugsPrincipal Investigator

    • Principal Investigator
      ZHAO SONGJI
    • Project Period (FY)
      2011 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University
  •  Early andspecific detection of unstable atherosclerotic pl:aqTuiesssue factor imaging using pre-targeting systems

    • Principal Investigator
      KUGE Yuji
    • Project Period (FY)
      2011 – 2012
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University
  •  Molecular imaging for dynamic analysis of cancer pathological states : Toward clinical molecular imaging

    • Principal Investigator
      KUGE Yuji
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University
  •  Assessment of coronary endothelial function using positron emission tomography

    • Principal Investigator
      YOSHINAGA Keiichiro
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Hokkaido University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Other

All Journal Article Presentation Book Patent

  • [Book] Molecular Imaging for Integrated Medical Therapy and Drug Development(Tamaki N, Kuge Y eds.)(Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy.)2010

    • Author(s)
      Kuge Y, Zhao S, Takei T, Tamaki N
    • Publisher
      Springer (Springer Science+Business Media), Heidelberger
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Journal Article] In vivo-stable bis-iminobiotin for targeted radionuclide delivery with the mutant streptavidin2024

    • Author(s)
      Toshifumi Tatsumi, Songji Zhao, Akitomo Kasahara, Miho Aoki, Ken-ichi Nishijima, Naoyuki Ukon, Tatsuhiko Kodama, Kazuhiro Takahashi, Akira Sugiyama, Kohshin Washiyama, Kenzo Yamatsugu, Motomu Kanai
    • Journal Title

      Bioorganic & Medicinal Chemistry Letters

      Volume: 108 Pages: 129803-129803

    • DOI

      10.1016/j.bmcl.2024.129803

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627, KAKENHI-ORGANIZER-22H05017, KAKENHI-PLANNED-22H05018, KAKENHI-PLANNED-22H05024, KAKENHI-PROJECT-22K07800, KAKENHI-PROJECT-21K15831, KAKENHI-PROJECT-24K18788
  • [Journal Article] Dose Dependent Effect of Sulfamethoxazole on Inhibiting K<sub>ATP</sub> Channel of Mouse Pancreatic β Cell2023

    • Author(s)
      Ogata Hiroshi、Kitamura Shigeki、Fujiwara Makoto、Shimizu Masaru、Tan Chengbo、Zhao Songji、Maejima Yuko、Shimomura Kenju
    • Journal Title

      Dose-Response

      Volume: 21 Issue: 3 Pages: 155-155

    • DOI

      10.1177/15593258231203611

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K08012, KAKENHI-PROJECT-20H03626
  • [Journal Article] Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)2021

    • Author(s)
      Takagi Hironori、Zhao Songji、Muto Satoshi、Yokouchi Hiroshi、Nishihara Hiroshi、Harada Toshiyuki、Dosaka-Akita Hirotoshi、Nakamura Koji、Inano Akihiro、Isobe Hiroshi、Suzuki Hiroyuki、et al.
    • Journal Title

      Lung Cancer

      Volume: 153 Pages: 134-142

    • DOI

      10.1016/j.lungcan.2021.01.014

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09310, KAKENHI-PROJECT-19K18223, KAKENHI-PROJECT-20H03626
  • [Journal Article] Evaluation of organ glucose metabolism by 18F-FDG accumulation with insulin loading in aged mice compared with young normal mice2021

    • Author(s)
      Zhao Jingmin、Tan Chengbo、Imai Ryota、Ukon Naoyuki、Shimoyama Saki、Maejima Yuko、Omiya Yuji、Takahashi Kazuhiro、Ito Hiroshi、Nan Guangxian、Zhao Songji、Shimomura Kenju
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 7421-7421

    • DOI

      10.1038/s41598-021-86825-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K08031, KAKENHI-PROJECT-20K08865, KAKENHI-PROJECT-21K15831, KAKENHI-PROJECT-18K08483, KAKENHI-PROJECT-20H03626
  • [Journal Article] Structure based analysis of KATP channel with a DEND syndrome mutation in murine skeletal muscle2021

    • Author(s)
      Horita Shoichiro、Ono Tomoyuki、Gonzalez-Resines Saul、Ono Yuko、Yamachi Megumi、Zhao Songji、Domene Carmen、Maejima Yuko、Shimomura Kenju
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 6668-6668

    • DOI

      10.1038/s41598-021-86121-5

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K16544, KAKENHI-PROJECT-20K08865, KAKENHI-PROJECT-18K08483, KAKENHI-PROJECT-20H03626
  • [Journal Article] Evaluation of Effect of Ninjin'yoeito on Regional Brain Glucose Metabolism by 18F-FDG Autoradiography With Insulin Loading in Aged Mice2021

    • Author(s)
      Zhao Jingmin、Imai Ryota、Ukon Naoyuki、Shimoyama Saki、Tan Chengbo、Maejima Yuko、Omiya Yuji、Takahashi Kazuhiro、Nan Guangxian、Zhao Songji、Ito Hiroshi、Shimomura Kenju
    • Journal Title

      Frontiers in Nutrition

      Volume: 8 Pages: 657663-657663

    • DOI

      10.3389/fnut.2021.657663

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K08031, KAKENHI-PROJECT-21K15831, KAKENHI-PROJECT-20H03626
  • [Journal Article] Responses of Immune Organs after Cerebral Ischemic Stroke2021

    • Author(s)
      Tan Chengbo、Wang Zifeng、Zheng Miao、Zhao Songji、Shichinohe Hideo、Houkin Kiyohiro
    • Journal Title

      Journal of Nippon Medical School

      Volume: 88 Issue: 3 Pages: 228-237

    • DOI

      10.1272/jnms.JNMS.2021_88-308

    • NAID

      130008059187

    • ISSN
      1345-4676, 1347-3409
    • Year and Date
      2021-06-25
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Journal Article] Simulation of the distribution of astatine-211 solution dispersion in a lab room2021

    • Author(s)
      Kubo Hitoshi、Takahashi Kazuhiro、Shimoyama Saki、Zhao Songji、Ukon Naoyuki、Ito Hiroshi
    • Journal Title

      Nuclear Medicine Communications

      Volume: 42 Issue: 9 Pages: 1052-1059

    • DOI

      10.1097/mnm.0000000000001430

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K08031, KAKENHI-PROJECT-21K15831, KAKENHI-PROJECT-20H03626
  • [Journal Article] Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody.2020

    • Author(s)
      Oriuchi N
    • Journal Title

      Sci. Rep.

      Volume: 10 Issue: 1 Pages: 6810-6810

    • DOI

      10.1038/s41598-020-63557-9

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18H03548, KAKENHI-PROJECT-19K08180, KAKENHI-PROJECT-20K08031, KAKENHI-PROJECT-20K21582, KAKENHI-PROJECT-19H03605, KAKENHI-PROJECT-20H03626
  • [Journal Article] Effects of feeding condition on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice2020

    • Author(s)
      Yamasaki Kazuaki、Zhao Songji、Nishimura Mie、Shimizu Yoichi、Tamaki Nagara、Takeda Hiroshi、Kuge Yuji
    • Journal Title

      Annals of Nuclear Medicine

      Volume: 35 Issue: 1 Pages: 59-64

    • DOI

      10.1007/s12149-020-01535-x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Journal Article] Preliminary Evaluation of Astatine-211-Labeled Bombesin Derivatives for Targeted Alpha Therapy2020

    • Author(s)
      Aoki Miho、Zhao Songji、Takahashi Kazuhiro、Washiyama Kohshin、Ukon Naoyuki、Tan Chengbo、Shimoyama Saki、Nishijima Ken-ichi、Ogawa Kazuma
    • Journal Title

      Chemical and Pharmaceutical Bulletin

      Volume: 68 Issue: 6 Pages: 538-545

    • DOI

      10.1248/cpb.c20-00077

    • NAID

      130007850061

    • ISSN
      0009-2363, 1347-5223
    • Year and Date
      2020-06-01
    • Language
      English
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08180, KAKENHI-PROJECT-18K07630, KAKENHI-PROJECT-20H03626
  • [Journal Article] Human dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) estimated using preclinical biodistribution from normal mice2020

    • Author(s)
      Ukon Naoyuki、Zhao Songji、Washiyama Kohshin、Oriuchi Noboru、Tan Chengbo、Shimoyama Saki、Aoki Miho、Kubo Hitoshi、Takahashi Kazuhiro、Ito Hiroshi
    • Journal Title

      EJNMMI Physics

      Volume: 7 Issue: 1 Pages: 58-58

    • DOI

      10.1186/s40658-020-00326-7

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K08031, KAKENHI-PROJECT-19H03605, KAKENHI-PROJECT-18K15556, KAKENHI-PROJECT-20H03627, KAKENHI-PROJECT-20H03626
  • [Journal Article] Biodistribution and Dosimetry of Free 211At and Meta-[211At]astatobenzylguanidine (MABG) in Normal Mice2019

    • Author(s)
      Ukon N, Zhao S, Washiyama K, Oriuchi N, Aoki M, Tan C, Shimoyama S, Nishijima Ken-ichi, Kubo H, Takahashi K, Ito H
    • Journal Title

      J Med Imaging Radiat Sci

      Volume: 50

    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Journal Article] Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models2019

    • Author(s)
      Zhao S, Yu W, Ukon N, Tan C, Nishijima K, Shimizu Y, Higashikawa K, Shiga T, Yamashita H, Tamaki N, Kuge Y.
    • Journal Title

      EJNMMI Res

      Volume: in press

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Journal Article] Comparative evaluation of 18F-DiFA and its analogues as novel hypoxia positron emission tomography and 18F-FMISO as the standard.2019

    • Author(s)
      Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima K, Shiga T, Tamaki N, Kuge Y, Matsumoto H.
    • Journal Title

      Nucl Med Biol

      Volume: 70 Pages: 39-45

    • DOI

      10.1016/j.nucmedbio.2019.01.008

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Journal Article] A novel PET probe [18F]DiFA accumulates in hypoxic region via glutathione conjugation following reductive metabolism.2019

    • Author(s)
      Shimizu Y, Zhao S, Yasui H, Nishijima K, Matsumoto H, Siga T, Tamaki N, Ogawa M, Kuge Y.
    • Journal Title

      Mol Imaging Biol

      Volume: 21 Issue: 1 Pages: 122-129

    • DOI

      10.1007/s11307-018-1214-y

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Journal Article] Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models2019

    • Author(s)
      Zhao Songji、Yu Wenwen、Ukon Naoyuki、Tan Chengbo、Nishijima Ken-ichi、Shimizu Yoichi、Higashikawa Kei、Shiga Tohru、Yamashita Hiroko、Tamaki Nagara、Kuge Yuji
    • Journal Title

      EJNMMI Research

      Volume: 9 Issue: 1 Pages: 51-51

    • DOI

      10.1186/s13550-019-0521-x

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08180, KAKENHI-PROJECT-18H02757
  • [Journal Article] In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate.2018

    • Author(s)
      Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y.
    • Journal Title

      Nucl Med Biol.

      Volume: 56 Pages: 21-25

    • DOI

      10.1016/j.nucmedbio.2017.08.003

    • NAID

      120006546743

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K08670, KAKENHI-PROJECT-16K10335, KAKENHI-PROJECT-16H05163, KAKENHI-PROJECT-18K19508
  • [Journal Article] [18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia2018

    • Author(s)
      Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Ukon N, Yasui H, Tamaki N, Kuge Y, Shichinohe H, Houkin K
    • Journal Title

      EJNMMI Res

      Volume: 8 Issue: 1 Pages: 35-35

    • DOI

      10.1186/s13550-018-0392-6

    • NAID

      120006482581

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Journal Article] A novel PET probe [18F]DiFA accumulates in hypoxic region via glutathione conjugation following reductive metabolism2018

    • Author(s)
      Shimizu Y, Zhao S, Yasui H, Nishijima K, Matsumoto H, Siga T, Tamaki N, Ogawa M, Kuge Y.
    • Journal Title

      Mol Imaging Biol

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Journal Article] Changes in tumor oxygen states after sorafenib therapy evaluated by 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft2017

    • Author(s)
      Yu W, Zhao S*, Zhao Y, Fatema CN, Murakami M, Nishijima K, Kitagawa Y, Tamaki N, Kuge Y
    • Journal Title

      Oncol Lett

      Volume: 14 Issue: 2 Pages: 2341-2346

    • DOI

      10.3892/ol.2017.6371

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K10335, KAKENHI-PROJECT-15F15420
  • [Journal Article] Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity2017

    • Author(s)
      Oshima N., Akizawa H., Kawashima H., Zhao S., Zhao Y., Nishijima K. I., Kitamura Y., Arano Y., Kuge Y. and Ohkura K.
    • Journal Title

      Nuclear medicine and biology

      Volume: 48 Pages: 16-25

    • DOI

      10.1016/j.nucmedbio.2017.01.006

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09886, KAKENHI-PROJECT-15K19810, KAKENHI-PROJECT-16K10335
  • [Journal Article] The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.2016

    • Author(s)
      Kobashi N, Matsumoto H, Zhao S, Meike S, Okumura Y, Abe T, Akizawa H, Ohkura K, Nishijima K, Tamaki N, Kuge Y.
    • Journal Title

      Journal of Nuclear Medicine

      Volume: 8 Issue: 8 Pages: 1276-1281

    • DOI

      10.2967/jnumed.115.165811

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26461782
  • [Journal Article] Relationship between biodistribution of a novel thymidine phosphorylase (TP) probe and TP expression levels in normal mice2015

    • Author(s)
      Zhao S., Li H.,Nishijima K.,,Zhao Y., Akizawa H,,Shimizu Y., Ohkura K., Tamaki N., KugeY.
    • Journal Title

      Anal.Nucl.Med

      Volume: 29 Issue: 7 Pages: 582-587

    • DOI

      10.1007/s12149-015-0981-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26461802
  • [Journal Article] Design, synthesis and biological evaluation of negatively charged 111In-DTPA-octreotide derivatives2014

    • Author(s)
      Oshima N, Akizawa H, Zhao S, Nishijima K, Kitamura Y, Arano Y, Kuge Y, Ohkura K
    • Journal Title

      Bioorgan Med Chem

      Volume: 22 Issue: 4 Pages: 1377-1382

    • DOI

      10.1016/j.bmc.2013.12.063

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742, KAKENHI-PROJECT-24591812, KAKENHI-PROJECT-24791329
  • [Journal Article] Biological characteristics of intratumoral [F-18] fluoromisonidazole distribution in a rodent model of glioma2013

    • Author(s)
      Hatano T, Zhao S, Zhao Y, Nishijima K, Kuno N, Hanzawa H, Sakamoto T, Tamaki N, Kuge Y
    • Journal Title

      Int J Oncol

      Volume: 42卷 Issue: 3 Pages: 823-830

    • DOI

      10.3892/ijo.2013.1781

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249065, KAKENHI-PROJECT-23591742
  • [Journal Article] Monitoring intratumoral proliferative responses to radiotherapy by 18F-fluorothymidine in a human head and neck cancer xenograft: comparison with Ki-67.2013

    • Author(s)
      Fatema CN, Zhao S, Zhao Y, Murakami M, Yu W, Nishijima K, Tamaki N, Kitagawa Y, Kuge Y.
    • Journal Title

      Ann Nucl Med

      Volume: 27 Issue: 4 Pages: 355-362

    • DOI

      10.1007/s12149-013-0693-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742, KAKENHI-PROJECT-25293406
  • [Journal Article] Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model2013

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Masahiro Yamasaki, Takiguchi M, Tamaki N, Kuge Y
    • Journal Title

      Oncology letters

      Volume: 6 Issue: 3 Pages: 667-672

    • DOI

      10.3892/ol.2013.1459

    • NAID

      120005385304

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Journal Article] Increased intratumoral fluorothymidine (FLT) uptake level after multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft.2013

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Masahiro Yamasaki, Takiguchi M, Tamaki N, Kuge Y.
    • Journal Title

      Oncology letters

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Journal Article] Reoxygenation-induced nitric oxide mitigates tumor hypoxia and radioresistance in a murine SCCVII tumor model2013

    • Author(s)
      Nagane M, Yasui H, Yamamori T, Zhao S, Kuge Y, Tamaki N, Kameya H, Nakamura H, Fujii H, Hirata H, Inanami O
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 437 Issue: 3 Pages: 420-425

    • DOI

      10.1016/j.bbrc.2013.06.093

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742, KAKENHI-PROJECT-24654112, KAKENHI-PROJECT-24659551, KAKENHI-PROJECT-25861045
  • [Journal Article] Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression2013

    • Author(s)
      Zhao S, Kuge Y, Zhao Y, Takeuchi S, Hirata K, Takei T, Shiga T, Dsaka-Akita H and Tamaki N
    • Journal Title

      BMC Cancer

      Volume: 13 Issue: 1 Pages: 525-525

    • DOI

      10.1186/1471-2407-13-525

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Journal Article] Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma2012

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Journal Title

      Int J Oncol

      Volume: 41卷 Issue: 5 Pages: 1593-1600

    • DOI

      10.3892/ijo.2012.1624

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249065, KAKENHI-PROJECT-23591742
  • [Journal Article] 医薬品開発(又は創薬・育薬)における分子イメージング技術の現状と進歩2012

    • Author(s)
      久下裕司、西嶋剣一、孫田恵一、趙松吉、玉木長良
    • Journal Title

      医薬品医療機器レギュラトリーサイエンス

      Volume: 43 Pages: 308-313

    • Data Source
      KAKENHI-PROJECT-23591742
  • [Journal Article] Dynamic 11 C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas : an experimental study using small animal PET2011

    • Author(s)
      Zhao S, Kuge Y, Yi M, Zhao Y, Hatano T, Magota K, Nishijima K, Kohanawa M, Tamaki N
    • Journal Title

      Eur J Nucl Med Mol Imaging

      Volume: 38 Issue: 10 Pages: 1876-1886

    • DOI

      10.1007/s00259-011-1865-2

    • NAID

      120004710960

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249065, KAKENHI-PROJECT-23591742
  • [Journal Article] ^<18>F-Fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts2011

    • Author(s)
      Takeuchi S, Zhao S, Kuge Y, Zhao Y, Nishijima K, Hatano T, Shimizu Y, Kinoshita I, Tamaki N, Dosaka-Akita H
    • Journal Title

      Oncol Rep

      Volume: 26 Pages: 725-730

    • DOI

      10.3892/or.2011.1338

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Journal Article] Radiolabeled uracil derivative as a novel SPECT probe for thymidine phosphorylase : suppressed accumulation into tumor cells by target gene knockdown2011

    • Author(s)
      Li H, Zhao S, Jin Y, Nishijima K, Akizawa H, Ohkura K, Tamaki N, Kuge Y
    • Journal Title

      Nucl Med Commun

      Volume: 32 Issue: 12 Pages: 1211-1215

    • DOI

      10.1097/mnm.0b013e32834b7ea7

    • NAID

      120004979488

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591742, KAKENHI-PROJECT-23591811, KAKENHI-PROJECT-23591826
  • [Journal Article] In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging.2010

    • Author(s)
      Akizawa H, Zhao S, Takahashi M, Nishijima K, Kuge Y, Tamaki N, Seki K, Ohkura K
    • Journal Title

      Nucl Med Biol. 37

      Pages: 427-432

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Journal Article] Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy.2009

    • Author(s)
      Kuge Y, Zhao S, Takei T, Tamaki N.
    • Journal Title

      Anti-Cancer Agents in Medicinal Chemistry. 9

      Pages: 1003-1011

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Journal Article] Comparison of 99m Tc-annexinA5 with 18F-FDG for the detection of atherosclerosis in Apo E-/- mice.2007

    • Author(s)
      Zhao Y, Kuge Y, Morita K, Inubushi M, Zhao S, Strauss HW, Blankenberg FG, Tamaki N.
    • Journal Title

      Eur J Nucl Med Mol Imaging 34

      Pages: 1747-1755

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591395
  • [Journal Article] Arterial 18F-fluorodeoxyglucose uptake reflects thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions

    • Author(s)
      Atsushi Yamashita, Yan Zhao, Songji Zhao, Yunosuke Matsuura, Chihiro Sugita, Takashi Iwakiri, Nozomi Okuyama, Kazuyo Ohe, Chihiro Koshimoto, Keiichi Kawai, Nagara Tamaki, Yuji Kuge, and Yujiro Asada
    • Journal Title

      Circulation Journal

      Volume: (In press)

    • Data Source
      KAKENHI-PROJECT-23659573
  • [Journal Article] Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging.

    • Author(s)
      Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N
    • Journal Title

      Eur J Nucl Med Mol Imaging. (印刷中)

    • NAID

      120003918916

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Patent] アルファ線放出核種で標識された抗CD20抗体2023

    • Inventor(s)
      池添隆之、趙松吉、織内昇、他
    • Industrial Property Rights Holder
      池添隆之、趙松吉、織内昇、他
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2023-109103
    • Filing Date
      2023
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Patent] アルファ線放出核種で標識された抗CD82抗体2022

    • Inventor(s)
      池添隆之, 趙松吉, 織内昇, 鈴木美穂, 立花太郎, 波田千彰
    • Industrial Property Rights Holder
      池添隆之, 趙松吉, 織内昇, 鈴木美穂, 立花太郎, 波田千彰
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2022-108025
    • Filing Date
      2022
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Evaluation of the potential of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CD82 monoclonal antibody in a murine xenograft model2024

    • Author(s)
      Songji Zhao, Noboru Oriuchi, Taro Tachibana, Ken-ichi Nishijima, Chiaki Hata, Naoyuki Ukon, Saki Shimoyama, Cai-Xia Wang, Taiki Joho, Akira Sugiyama, Kohshin Washiyama, Kazuhiro Takahashi, Takayuki Ikezoe
    • Organizer
      Society of Nuclear Medicine and Molecular Imaging 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Presentation] 悪性褐色細胞腫PC12移植マウスにおける211At-MABGと123I-MIBGイメージングの体内動態及び線量評価の比較2023

    • Author(s)
      右近直之、ZHAO Songji、鷲山幸信、西嶋剣一、織内昇、下山彩希、城寳大輝、志賀哲、高橋和弘、伊藤浩
    • Organizer
      第35回バイオメディカル分析科学シンポジウム
    • Data Source
      KAKENHI-PROJECT-22K07800
  • [Presentation] 福島県立医科大学およびF-REIにおけるAt-211を用いたTargeted Alpha therapy (TAT) の開発2023

    • Author(s)
      志賀哲、高橋和弘、小早川雅男、菅原茂耕、西嶋剣一、織内昇、伊藤浩、野村香織、右近直之、趙松吉
    • Organizer
      第63回日本核医学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07800
  • [Presentation] Pretargeted alpha radioimmunotherapy for the treatment of gastric cancer using low-immunogenic mutated streptavidin and 211At labeled modified bis-iminobiotin2023

    • Author(s)
      Kohshin Washiyama, Toshifumi Tatsumi, Akira Sugiyama, Songji Zhao, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      12th International Symposium on Targeted Alpha Therapy
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Possibility of 123I-meta-iodobenzylguanidine (MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal and pheocheomocytoma xenograft mice2023

    • Author(s)
      Songji Zhao, Naoyuki Ukon, Saki Shimoyama, Jingmin Zhao, Taiki Joho, Ken-ichi Nishijima, Kohshin Washiyama, Kazuhiro Takahashi, Masao Kobayakawa, Tohru Shiga, Noboru Oriuchi, Hiroshi Ito
    • Organizer
      SNMMI 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Presentation] Pretargeted alpha radioimmunotherapy for the treatment of gastric cancer using low-immunogenic mutated streptavidin and 211At labeled modified bis-iminobiotin2023

    • Author(s)
      Kohshin Washiyama, Akira Sugiyama, Songji Zhao, Toshifumi Tatsumi, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Noboru Oriuchi , Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      TAT12 International Symposium
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Presentation] Delivery of α-particles by a human-rat chimeric CD82 monoclonal antibody potently inhibits the proliferation of CD82-expressing acute myeloid leukemia cells in a murine xenograft model2023

    • Author(s)
      Takayuki Ikezoe, Taro Tachibana, Noboru Oriuchi, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Kohshin Washiyama, Kazuhiro Takahashi, Songji Zhao
    • Organizer
      ASH Annual Meeting & Exposition 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Presentation] 悪性褐色細胞腫PC12移植マウスにおける211At-MABGと123I-MIBGイメージングの体内動態及び線量評価の比較2023

    • Author(s)
      右近直之、趙松吉、鷲山幸信、西嶋剣一、織内昇、下山彩希, 城寳大輝, 志賀哲, 高橋和弘、伊藤浩
    • Organizer
      第35回バイオメディカル分析化学シンポジウム
    • Data Source
      KAKENHI-PROJECT-23K27555
  • [Presentation] Synthesis of an 211At labelled bis-iminobiotin derivativewith enhanced plasma stability2022

    • Author(s)
      Kohshin Washiyama, Toshifumi Tatsumi, Akira Sugiyama, Songji Zhao, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      2022 JSNM Annual Meeting
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Synthesis and evaluation of 211At-labeled bis-iminobiotin for pretargeted alpha radioimmunotherapy2022

    • Author(s)
      Kohshin Washiyama, Toshifumi Tatsumi, Akira Sugiyama, Songji Zhao, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      2022 SNMMI Annual Meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] 悪性褐色細胞腫PC12移植マウスにおける123I-MIBGイメージングとex-vivo体内動態及び線量評価の比較2022

    • Author(s)
      右近直之、趙松吉、鷲山幸信、西嶋剣一、下山彩希、城寳大輝、志賀哲、織内昇、髙橋和弘、伊藤浩
    • Organizer
      第62回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Effects of single and repeated 211At-MABG treatments on tumor growth suppression in a pheochromocytoma xenograft2022

    • Author(s)
      Zhao S, Aoki M, Ukon N, Shimoyama S, Nishijima KI, Joho T, Washiyama K, Washino K, Shiga T, Oriuchi N, Takahashi K, Higashi T, Ito H.
    • Organizer
      The 69th Society of Nuclear Medicine Annual Meeting- Virtual Edition (SNMMI 2022)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Synthesis and evaluation of 211At-labeled bis-iminobiotin for pretargeted alpha radioimmunotherapy2022

    • Author(s)
      Washiyama K, Sugiyama A, Tatsumi T, Zhao S, Aoki M, Yamatsugu K, Ukon N, Shimoyama S, Nishijima K, Joho T, Shiga T, Inano A, Oriuchi N, Kanai M, Takahashi K, Kodama T
    • Organizer
      The 69th Society of Nuclear Medicine Annual Meeting- Virtual Edition (SNMMI 2022)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Similarities and differences of dosimetry between meta-[211At]astatobenzylguanidine (211At-MABG) and meta-[123I]iodobenzylguanidine (123I-MIBG) as companion diagnostic drug in PC12 pheochromocytoma model mice2022

    • Author(s)
      Ukon N, Zhao S, Washiyama K, Nishijima K, Shimoyama S, Joho T, Oriuchi N, Shiga T, Takahashi K, Ito H
    • Organizer
      Annual Congress of the European Association of Nuclear Medicine (EANM'22)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 急性骨髄性白血病における211At標識抗CD82抗体の治療効果2022

    • Author(s)
      趙 松吉、粟生木美穂、趙 景敏、右近 直之、下山 彩希、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之
    • Organizer
      第3回放射線災害・医科学研究拠点ワークショップ
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 低免疫原性ストレプトアビジン変異体と改変ビオチンを用いるプレターゲティングシステムの開発2022

    • Author(s)
      巽 俊文、山次 健三、杉山 暁、趙 松吉、粟生木 美穂、西嶋 剣一、右近 直之、下山 彩希、譚 成博、城寶 大輝、織内 昇、高橋 和弘、清水 洋平、高橋 和希、安藝 翔、児玉 龍彦、鷲山 幸信、金井 求
    • Organizer
      日本放射線化学会第66回討論会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 新規イメージング技術を用いたα線放出核種の組織内局所線量評価の基礎検討2021

    • Author(s)
      右近 直之, 鷲山 幸信, 趙 松吉, 織内 昇, 西嶋 剣一, 城寳 大輝, 下山 彩希, 高橋 和弘, 伊藤 浩
    • Organizer
      第58回アイソトープ・放射線研究発表会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 褐色細胞腫モデルにおける 211At-MABGの反復投与による腫瘍成長の抑制効果の評価2021

    • Author(s)
      趙 松吉、粟生木美穂、右近 直之、西嶋 剣一、鷲野 弘明、志賀 哲、織内 昇、高橋 和弘、東 達也、伊藤 浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] Evaluation of effect of Ninjin'yoeito on regional brain glucose metabolism by 18F-FDG autoradiography with insulin loading in superaged mice2021

    • Author(s)
      Zhao J, Imai R, Ukon N, Shimoyama S, Tan C, Maejima Y, Omiya Y, Takahashi K, Nan G, Zhao S, Ito H, Shimomura K
    • Organizer
      The 68th Society of Nuclear Medicine Annual Meeting- Virtual Edition (SNMMI 2021)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] ヒト急性白血病モデルマウスにおける211At-CD33の体内動態2021

    • Author(s)
      下山 彩希、粟生木美穂、趙 景敏、右近 直之、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之、趙 松吉
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 正常マウスにおけるフリー 211Atの臓器毒性評価2021

    • Author(s)
      趙 松吉、粟生木美穂、右近 直之、下山 彩希、西嶋 剣一、鷲山 幸信、志賀 哲、織内 昇、高橋 和弘、伊藤 浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 正常マウスにおける211At-MABGの臓器毒性と線量評価の検討2021

    • Author(s)
      右近 直之、趙松吉、鷲山 幸信、下山 彩希、西嶋 剣一、鷲野 弘明、志賀 哲、織内 昇、高橋 和弘、東 達也、伊藤 浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] ヒト急性白血病モデルマウスにおける211At-CD82の体内動態2021

    • Author(s)
      趙 松吉、粟生木美穂、下山 彩希、趙 景敏、右近 直之、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 新規イメージング技術を用いたα線放出核種の組織内局所線量評価の基礎検討2021

    • Author(s)
      右近 直之, 鷲山 幸信, 趙 松吉, 織内 昇, 西嶋 剣一, 城寳 大輝, 下山 彩希, 高橋 和弘, 伊藤 浩
    • Organizer
      第58回アイソトープ・放射線研究発表会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] 第1相試験に向けた211At-MABGの非臨床開発戦略2021

    • Author(s)
      鷲野弘明、高橋和弘、小早川雅男、趙松吉、吉岡菜穂、下山彩希、右近直之、伊藤浩、東達也
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 悪性褐色細胞腫PC12移植マウスにおける123I-MIBGと211At-MABGの体内動態及び線量評価2021

    • Author(s)
      右近直之、趙松吉、鷲山幸信、西嶋剣一、織内昇、下山彩希、城寳大輝、志賀哲、髙橋和弘、伊藤浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 急性骨髄性白血病における211At標識抗CD82抗体の治療効果2021

    • Author(s)
      趙 松吉、粟生木美穂、趙 景敏、右近 直之、下山 彩希、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 急性骨髄性白血病における211At標識抗CD82抗体の治療効果2021

    • Author(s)
      趙 松吉、粟生木美穂、趙 景敏、右近 直之、下山 彩希、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之。
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Evaluation of acute radiotoxicity profile of alpha-particle-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal BALB/c mice2021

    • Author(s)
      Zhao S, Washino k, Aoki M, Ukon N, Shimoyama S, Nishijima K, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      The 68th Society of Nuclear Medicine Annual Meeting- Virtual Edition (SNMMI 2021)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 褐色細胞腫モデルにおける211At-MABGの反復投与による腫瘍成長の抑制効果の評価2021

    • Author(s)
      趙松吉;粟生木美穂;下山彩希、右近直之、西嶋剣一、鷲野弘明、志賀哲、織内昇、髙橋和弘、東達也、伊藤浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Targeted delivery of 211At with low immunogenic mutant streptavidin-bisiminobiotin pre-targeting system2021

    • Author(s)
      Toshifumi Tatsumi, Kenzo Yamatsugu, Akira Sugiyama, Songji Zhao, Miho Aoki, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Chengbo Tan, Fengying Gao, Taiki Joho, Noboru Oriuchi, Kazuhiro Takahashi, Motomu Kanai, Tatsuhiko Kodama, Kohshin Washiyama
    • Organizer
      The 2021 International Chemical Congress of Pacific Basin Societies
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] ヒト急性白血病モデルマウスにおける211At-CD33の体内動態2021

    • Author(s)
      下山 彩希、粟生木美穂、趙 景敏、右近 直之、西嶋 剣一、鷲山 幸信、高橋 和弘、伊藤 浩、織内 昇、池添 隆之、趙 松吉
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 悪性褐色細胞腫PC12移植マウスにおける123I-MIBGと211At-MABGの体内動態及び線量評価2021

    • Author(s)
      右近 直之、趙松吉、鷲山 幸信、西嶋 剣一、志賀 哲、織内 昇、下山 彩希、城寶大輝、高橋 和弘、伊藤 浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 高齢マウスの局所脳糖代謝に対する人参栄養湯の効果:インシュリン負荷による18F-FDG オートラジオグラフィーの画像手法を用いた評価2021

    • Author(s)
      趙景敏、今井亮太、右近直之、下山彩希、前島裕子、大宮雄司、髙橋和弘、南光賢、趙松吉、下村健寿、伊藤浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Correlation of radiotoxicity and dosimetry of 211At-MABG in normal mice2021

    • Author(s)
      右近直之、趙松吉、鷲山幸信、下山彩希、西嶋剣一、鷲野弘明、志賀 哲、織内昇、髙橋和弘、伊藤浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 正常マウスにおけるフリー 211Atの臓器毒性評価2021

    • Author(s)
      趙 松吉、粟生木美穂、右近 直之、下山 彩希 、西嶋 剣一、鷲山 幸信、志賀 哲、織内 昇、高橋 和弘、伊藤 浩
    • Organizer
      第61回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 進行癌におけるCupidと211At標識Psyche-Bを用いたプレターゲティング法の治療効果評価2020

    • Author(s)
      趙松吉, 右近直之, 織内昇, 高峰英, 下山彩希, 高橋和弘, 巽俊文, 山次健三, 金井求, 杉山暁, 児玉龍彦
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Differences and similarities in biodistribution, pharmacokinetics and metabolites of 211At-MABG versus 123I-MIBG in normal mice2020

    • Author(s)
      Washino K, Zhao S, Yoshinaga K, Ito Y, Aoki M, Ukon N, Shimoyama S, Nishijima K, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Ito H, Higashi T
    • Organizer
      The 67th Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 進行がん治療を指向した低免疫原性ストレプトアビジン変異体と 211At標識イミノビオチンを用いるプレターゲティングシステムの開発2020

    • Author(s)
      巽俊文, 山次健三, 清水洋平, 杉山暁, 趙松吉, 粟生木美穂, 西嶋剣一, 右近直之, 高橋和弘, 児玉龍彦, 鷲山幸信, 金井求
    • Organizer
      反応と合成の進歩2020特別企画シンポジウム|
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Evaluation of therapeutic effect of the targeted alpha therapy using Cupid-211At-labeled Psyche-B pretargeting system in a human gastric cancer cell xenograft2020

    • Author(s)
      Zhao S, Sugiyama A, Ukon N, Shimoyama S, Tatsumi T, Aoki M, Gao F, Yamatsugu K, Nishijima K, Joho T, Oriuchi N, Takahashi K, Kanai M, Kodama T, Washiyama K
    • Organizer
      Annual Congress of the European Association of Nuclear Medicine (EANM'20)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 正常マウスにおける211At-MABGの毒性評価2020

    • Author(s)
      趙松吉, 吉永恵一郎, 粟生木美穂, 右近直之, 下山彩希, 西嶋剣一, 鷲山幸信, 鷲野弘明, 高橋和弘, 東達也, 伊藤浩
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] イミノビオチン誘導体の合成とアスタチン標識の検討2020

    • Author(s)
      粟生木美穂, 巽俊文, 西嶋剣一, 山次健三, 城寶大輝, 趙松吉, 杉山暁, 児玉龍彦, 高橋和弘, 金井求, 鷲山幸信
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] コンパニオン診断薬としての123I-MIBGから推定した211At-MABGの線量評価検討2020

    • Author(s)
      右近直之, 趙松吉, 鷲野弘明, 吉永恵一郎, 粟生木美穂, 西嶋剣一, 鷲山幸信, 織内昇, 高橋和弘, 東達也, 伊藤浩
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] 211At標識イミノビオチンを用いたプリターゲティング法の最適化 投与間隔による薬物動態評価2020

    • Author(s)
      右近直之、鷲山幸信、杉山暁、巽俊文、山次健三、下山彩希、織内昇、金井求、児玉龍彦、高橋和弘、趙松吉
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Evaluation of therapeutic effect of the targeted alpha therapy using Cupid-211At-labeled Psyche-B pretargeting system in a human gastric cancer cell xenograft2020

    • Author(s)
      Songji Zhao, Akira Sugiyama, Naoyuki Ukon, Saki Shimoyama, Toshifumi Tatsumi, Miho Aoki, Fengying Gao , Kenzo Yamatsugu, Ken-ichi Nishijima, Taiki Joho, Noboru Oriuchi, , Kazuhiro Takahashi1, Motomu Kanai, Tatsuhiko Kodama, Kohshin Washiyama
    • Organizer
      EANM 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] Search for the optimal bis-iminobiotin for the pretargeting strategy using a mutated low immunogenic streptavidin2020

    • Author(s)
      K. Washiyama, T. Tatsumi, S. Zhao, A. Sugiyama, M. Aoki, K. Yamatsugu, N. Ukon, K. Nishijima, S. Shimoyama, C. Tan, T. Joho, N. Oriuchi, M. Kanai, K. Takahashi, T. Kodama
    • Organizer
      33th Annual Congress of the European Association of Nuclear Medicine
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] α放射体211At標識イミノビオチンの作成と安定性評価2020

    • Author(s)
      鷲山幸信、粟生木美穂、巽俊文、山次健三、杉山暁、西嶋剣一、城寶大輝、高峰英、趙松吉、金井求、児玉龍彦、高橋和弘
    • Organizer
      日本放射化学会第64回討論会(2020)
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] 正常マウスにおける211At-MABGの 血液毒性の用量反応関係2020

    • Author(s)
      鷲野弘明, 趙 松吉, 下山彩希, 吉岡菜穂, 伊東奈津江, 粟生木美穂, 右近直之, 吉永恵一郎, 高橋和弘, 伊藤 浩, 東 達也
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Preclinical evaluation of cancer stem cell targeted therapy with 211At-labeled anti-CXCR4 antibody2020

    • Author(s)
      Oriuchi N, Zhao S, Aoki M, Tan C, Shimoyama S, Nishijima K, Washiyama K, Takahashi K, Sugawara S, Ito H, Ikezoe T
    • Organizer
      日本放射線影響学会 第63回大会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 正常マウスにおける211At-MABGの 血液毒性の用量反応関係2020

    • Author(s)
      鷲野 弘明、趙 松吉、下山彩希、吉岡菜穂、伊東奈津江、粟生木美穂、右近直之、吉永恵一郎、高橋和弘、伊藤 浩、東 達也
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Evaluation of therapeutic effect of the targeted alpha therapy using Cupid-211At-labeled Psyche-B pretargeting system in a human gastric cancer cell xenograft2020

    • Author(s)
      Songji Zhao, Akira Sugiyama, Naoyuki Ukon, Saki Shimoyama, Toshifumi Tatsumi, Miho Aoki, Fengying Gao, Kenzo Yamatsugu, Ken-ichi Nishijima, Taiki Joho, Noboru Oriuchi, Kazuhiro Takahashi, Motomu Kanai, Tatsuhiko Kodama, Kohshin Washiyama
    • Organizer
      33th Annual Congress of the European Association of Nuclear Medicine
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] 正常マウスにおける211At-MABGの毒性評価2020

    • Author(s)
      趙松吉、吉永恵一郎、粟生木美穂、右近直之、下山彩希、西嶋剣一、鷲山幸信、鷲野弘明、高橋和弘、東達也、伊藤浩
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] プレターゲティングへの応用を目指した211At標識改変イミノビオチンの体内分布測定2020

    • Author(s)
      鷲山幸信, 巽俊文, 杉山暁, 粟生木美穂, 譚成博, 下山彩希, 山次健三, 金井求, 児玉龍彦, 趙松吉, 高橋和弘
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] 正常マウスにおける211At-MABG と123I-MIBGの放射線線量の比較評価2020

    • Author(s)
      Zhao S, Ukon N, Yoshinaga K, Washino K, Aoki M, Nishijima K, Shimoyama S, Tan C, Washiyama K, Oriuchi N, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      日本放射線影響学会第63回大会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 褐色細胞腫モデルにおける211At-MABGと 131I-MIBGの抗腫瘍効果および安全性の比較2020

    • Author(s)
      Yoshinaga K, Zhao S, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Gao F, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Effects of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared to 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model2020

    • Author(s)
      Yoshinaga K, Zhao S, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Gao F, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Ito H, Higashi T
    • Organizer
      ENDO2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Search for the optimal bis-iminobiotin for the pretargeting strategy using a mutated low immunogenic streptavidin2020

    • Author(s)
      K Washiyama, T Tatsumi, S Zhao, A Sugiyama, M Aoki, K Yamatsugu, N Ukon, K Nishijima, S Shimoyama, C Tan, T Joho, N Oriuchi, M Kanai, K Takahashi, T Kodama
    • Organizer
      EANM 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] Effects and safety of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared with 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model2020

    • Author(s)
      Zhao S, Yoshinaga K, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Gao F, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      The 67th Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Effects and safety of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared with 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model.2020

    • Author(s)
      Zhao S, Yoshinaga K, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Gao F, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      2020米国核医学・分子イメージング学会
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Feasibility of cancer stem cells-targeted radioimmunotherapy for acute myelogenous leukemia with 211At-CXCR4 monoclonal antibody2020

    • Author(s)
      Oriuchi N, Aoki M, Ukon N, Washiyama K, Shimoyama S, Nishijima K, Takahashi K, Ito H, Ikezoe K, Zhao S
    • Organizer
      The 67th Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Targeted delivery of 211At with low immunogenic mutant streptavidin-bisiminobiotin pre-targeting system2020

    • Author(s)
      Toshifumi Tatsumi, Kenzo Yamatsugu, Akira Sugiyama, Songji Zhao, Miho Aoki, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Chengbo Tan, Fengying Gao, Taiki Joho, Noboru Oriuchi, Kazuhiro Takahashi, Motomu Kanai, Tatsuhiko Kodama, Kohshin Washiyama
    • Organizer
      Pacifichem2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] Feasibility of cancer stem cells-targeted radioimmunotherapy for acute myelogenous leukemia with 211At-CXCR4 monoclonal antibody.2020

    • Author(s)
      Oriuchi N, Aoki M, Ukon N, Washiyama K, Shimoyama S, Nishijima K, Takahashi K, Ito H, Ikezoe K, Zhao S
    • Organizer
      2020米国核医学・分子イメージング学会
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] コンパニオン診断薬としての123I-MIBGから推定した211At-MABGの線量評価検討2020

    • Author(s)
      右近直之、趙松吉、鷲野弘明、吉永恵一郎、粟生木美穂、西嶋剣一、鷲山幸信、織内昇、高橋和弘、東達也、伊藤浩
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] Biodistribution and dosimetry studies for optimization of pre-targeted radionuclide therapy in 211At labeled modified biotin2020

    • Author(s)
      Naoyuki Ukon, Kohshin Washiyama, Akira Sugiyama, Songji Zhao, Toshifumi Tatsumi, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Saki Shimoyama, Chengbo Tan, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      EANM 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 色細胞腫モデルにおける211At-MABGと 131I-MIBGの抗腫瘍効果および暗線性の比較2020

    • Author(s)
      Yoshinaga K, Zhao S, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Gao F, Washiyama K, Ito N, Yoshioka N, Tamura N, Takahashi K, Higashi T, Ito H
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Development of a pre-targeting strategy of low-immunogenic mutated streptavidin with 211At labeled modified biotin for advanced cancer treatment2020

    • Author(s)
      Kohshin Washiyama, Akira Sugiyama, Songji Zhao, Toshifumi Tatsumi, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Naoyuki Ukon, Saki Shimoyama, Chengbo Tan, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      SNMMI 2020 Annual Meeting - Virtual Edition
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Stem cells targeted radioimmunotherapy of acute myelogenous leukemia with 211At-labeled anti-CXCR4 monoclonal antibody2020

    • Author(s)
      Oriuchi N, Aoki M, Ukon N, Washiyama K, Shimoyama S, Nishijima K, Takahashi K, Ito H, Ikezoe T, Zhao S
    • Organizer
      SNMMI 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 211At標識イミノビオチンを用いたプリターゲティング法の最適化 投与間隔による薬物動態評価2020

    • Author(s)
      右近直之, 鷲山幸信, 杉山暁, 巽俊文, 山次健三, 下山彩希, 織内昇, 金井求, 児玉龍彦, 高橋和弘, 趙松吉
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] Biodistribution and dosimetry studies for the optimization of pre-targeted radionuclide therapy using 211At-labeled modified biotin2020

    • Author(s)
      Kohshin Washiyama, Akira Sugiyama, Songji Zhao, Toshifumi Tatsumi, Miho Aoki, Kenzo Yamatsugu, Ken-ichi Nishijima, Saki Shimoyama, Taiki Joho, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      33th Annual Congress of the European Association of Nuclear Medicine
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] α放射体211Atを用いたプレターゲティング法による進行がんの治療2020

    • Author(s)
      Kohshin Washiyama, Akira Sugiyama, Kenzo Yamatsugu, Songji Zhao, Toshifumi Tatsumi, Miho Aoki, Naoyuki Ukon, Saki Shimoyama, Ken-ichi Nishijima, Chengbo Tan, Taiki Joho, Fengying Gao, Noboru Oriuchi, Motomu Kanai, Kazuhiro Takahashi, Tatsuhiko Kodama
    • Organizer
      日本放射線影響学会第63回大会
    • Data Source
      KAKENHI-PROJECT-20H03627
  • [Presentation] ヒト胃癌細胞移植担癌モデル動物におけるドラッグデリバリーシステム(Cupid-Psycheシステム)を用いたアルファ線の治療効果。2020

    • Author(s)
      Zhao S, Sugiyama A, Shimoyama S, Tatsumi T, Ukon N, Gao F, Aoki M, Yamatsugu K, Takahashi K, Kanai M, Washiyama K
    • Organizer
      第60回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-20H03626
  • [Presentation] 小動物用SPECT装置を用いた211Atによる画像化の基礎検討2019

    • Author(s)
      右近 直之, 趙 松吉, 鷲山 幸信, 織内 昇, 粟生木 美穂, 西嶋 剣一, 譚 成博, 下山 彩希, 久保 均, 高橋 和弘, 伊藤 浩
    • Organizer
      第14回日本分子イメージング学会学術総会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Theranostics in Japan and current status of Fukushima Medical University2019

    • Author(s)
      N. Oriuchi, S. Zhao, M. Aoki, C. Tan, S. Sugawara, K.-I. Nishijima, S. Shimoyama, K. Washiyama, K. Takahashi, T. Ikezoe, H. Ito
    • Organizer
      Theranostics World Congress 2019
    • Invited
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 211At-MABG吸収線量評価におけるコンパニオン診断薬123I-MIBGの活用 核医学2019

    • Author(s)
      吉永 恵一郎, 趙 松吉, 粟生木 美穂, 右近 直之, 下山 彩希, 西嶋 剣一, 鷲山 幸信, 鷲野 弘明, 高橋 和弘, 伊藤 浩, 東 達也
    • Organizer
      第59回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Radiolabeling and biodistribution in the tumor xenograft of 211At-labeled anti-CXCR4 antibody for cancer stem cell targeted alpha-particle therapy.2019

    • Author(s)
      N. Oriuchi, S. Zhao, M. Aoki, C. Tan, S. Sugawara, K.-I. Nishijima, S. Shimoyama, K. Washiyama, K. Takahashi, T. Ikezoe, H. Ito
    • Organizer
      EANM’19
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] Synthesis of [211At]MABG Using Remote-controlled Synthesizer and Quality Evaluation2019

    • Author(s)
      M. Aoki, K. Minegishi, K. Nishijima, H. Suzuki, S. Sasaki, K. Washiyama, S. Zhao, K. Nagatsu, M. Zhang, K. Takahashi
    • Organizer
      The 23rd International Symposium on Radiopharmaceutical Sciences
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] 正常マウスにおける123I-MIBGと211At-MABGの体内動態の評価2019

    • Author(s)
      趙 松吉, 吉永 恵一郎, 粟生木 美穂, 右近 直之, 下山 彩希, 西嶋 剣一, 鷲山 幸信, 鷲野 弘明, 高橋 和弘, 東 達也, 伊藤 浩
    • Organizer
      第59回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] [211At]MABGの薄層クロマトグラフィー手順の探索2019

    • Author(s)
      粟生木 美穂, 西嶋 剣一, 鷲山 幸信, 城寶 大輝, 下山 彩希, 右近 直之, 趙 松吉, 鷲野 弘明, 高橋 和弘, 東 達也, 伊藤 浩
    • Organizer
      第59回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] 正常マウスにおける211At-MABGの薬物動態と代謝産物の予備的評価2019

    • Author(s)
      鷲野 弘明, 趙 松吉, 粟生木 美穂, 右近 直之, 下山 彩希, 西嶋 剣一, 鷲山 幸信, 吉永 恵一郎, 高橋 和弘, 伊藤 浩, 東 達也
    • Organizer
      第59回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Biodistribution of 211At-labeled anti-CXCR4 antibody in tumor xenograft2019

    • Author(s)
      N. Oriuchi, S. Zhao, M. Aoki, C. Tan, S. Sugawara, K. Nishijima, S. Shimoyama, K. Washiyama, K. Takahashi, T. Ikezoe, H. Ito
    • Organizer
      日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19H03605
  • [Presentation] 211At標識抗CXCR4抗体の腫瘍移植マウスにおける体内分布2019

    • Author(s)
      織内 昇, 趙 松吉, 粟生木 美穂, 譚 成博, 右近 直之, 西嶋 剣一, 鷲山 幸信, 高橋 和弘, 池添 隆之, 伊藤 浩
    • Organizer
      第59回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K08180
  • [Presentation] Biodistribution of free 211At and meta-[211At]astatobenzylguanidine (MABG) in normal mice.2018

    • Author(s)
      Zhao S, Aoki M, Washiyaoyma K, Ukon N, Tan C, Shimama S, Kubo H, Oriuchi N, Takahashi K, Ito H, Takenoshita S.
    • Organizer
      第58回日本核医学会学術総会
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] Targeted Alpha Therapy in Japan - Where we are in 2018-2018

    • Author(s)
      Oriuchi N, Washiyama K, Nishijima K, Aoki M, Zhao S, Ukon N, Takahashi K
    • Organizer
      EANM’19
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05393
  • [Presentation] Biodistribution of free 211At and meta-[211At]astatobenzylguanidine (MABG) in normal mice2018

    • Author(s)
      Songji Zhao, Miho Aoki, Kohshin Washiyama, Naoyuki Ukon, Chengbao Tan, Saki Shimoyama, Hitoshi Kubo, Noboru Oriuchi, Kazuhiro Takahashi, Hiroshi Ito, Seiichi Takenoshita
    • Organizer
      第58回日本核医学会総会
    • Data Source
      KAKENHI-PROJECT-16H05393
  • [Presentation] Investigation of the influence of intratumoral glutathione status on the distribution of a hypoxic probe [18F]FMISO.2018

    • Author(s)
      Yasui H, Higashikawa K, Shimizu Y, Shibata Y, Zhao S, Matsumoto H, Shiga T, Tamaki N, Kuge Y.
    • Organizer
      WFNMB 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] Effect of eribulin on remodeling of tumor vasculature confirmed by FMISO PET imaging-Small-animal PET study in human breast cancer cell xenograft-2017

    • Author(s)
      Zhao S, Yu W, Ukon N, Nishijima K, Shimizu Y, Higashikawa K, Yamashita H, Tamaki N, Kuge Y.
    • Organizer
      The 64th Society of Nuclear Medicine Annual Meeting in Denver
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] 小動物インビボイメージングの有用性2017

    • Author(s)
      趙 松吉、久下 裕司、玉木 長良
    • Organizer
      第26回日本バイオイメージング学会 シンポジウム
    • Invited
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] Accumulation mechanism of novel PET imaging probe “[18F]DiFA” in hypoxic cells revealed by imaging mass spectrometry.2017

    • Author(s)
      Shimizu Y, Zhao S, Kishi R, Yasui H, Nishijima K, Matsumoto H, Tamaki N, Ogawa M, Kuge Y.
    • Organizer
      The 64th Society of Nuclear Medicine Annual Meeting in Denver
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] The Production of 211At at Fukushima Medical University2017

    • Author(s)
      Miho Aoki, Hideyuki Tominaga Jun Kato, Takashi Oda, Songji Zhao, Toshikazu Hiasa, Noboru Oriuchi, Seiichi Takenoshita
    • Organizer
      10th International Symposium on Targeted Alpha Therapy
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05393
  • [Presentation] Production of At-211 by in-house cyclotron and characterization at Fukushima Medical University2017

    • Author(s)
      Noboru Oriuchi, Hideyuki Tominaga, Songji Zhao, Miho Aoki, Seiichi Takenoshita, Takashi Oda, Ming-Rong Zhang, Kotaro Nagatsu, Tatsuya Higashi, Noriko Ishioka
    • Organizer
      日本医学放射線学会総会
    • Data Source
      KAKENHI-PROJECT-16H05393
  • [Presentation] 日本甲状腺癌治療の現状及び展望2017

    • Author(s)
      趙 松吉
    • Organizer
      2017年国家級継続医学教育項目‐分化型甲状腺癌治療新進展。中国延辺大学医学部附属医院核医学国際シンポジウム
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] Preclinical and Translational Research on a Novel Thymidine Phophorylase (TP) Imaging Probe, 123I-IIMU Using SPECT2017

    • Author(s)
      Songji Zhao
    • Organizer
      BIT's 11th World Congress of Regenerative Medicine & Stem Cell 2017 in Singapore
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K10335
  • [Presentation] Preclinical and translational researchs novel PET and SPECT tracers: 18F-Difa and 123I-IIMU for hypoxia and thymidine phosphorylase imaging2015

    • Author(s)
      Zhao S., Nishijima K., Matsumoto H., Akizawa H., Ohkura K., Tamaki N., Kuge Y.
    • Organizer
      アジアオセアニア核医学・生物学会(AOCNMB 2015)
    • Place of Presentation
      韓国チェジュ
    • Year and Date
      2015-10-31
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26461802
  • [Presentation] Preclinical evaluation of thymidine phosphorylase imaging probe, [123I]IIMU, A road to First-in-human clinical study2015

    • Author(s)
      Nishijima K, Zhao S, Matsumoto H, Akizawa H, Ohkura K, Shiga T, Hirata K, Watanabe S, Okamoto S, Tamaki N, Kuge Y
    • Organizer
      Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry
    • Place of Presentation
      放射線医学総合研究所(千葉県・稲毛市)
    • Year and Date
      2015-11-08
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26461782
  • [Presentation] 肉芽腫・腫瘍の鑑別診断における18F-FMISO低酸素イメージング:小動物用PETを用いたラットモデルにおける14C-FDGとの比較2014

    • Author(s)
      趙 松吉、久下 裕司、伊敏、趙 芫、西嶋 剣一、于 聞文、孫田 恵一、玉木 長良
    • Organizer
      日本分子イメージング学会第9回総会・学術集会
    • Place of Presentation
      千里ライフサイエンスセンター(大阪市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 抗血管新生剤(sorafenib)の抗腫瘍効果の機序:肺癌細胞移植モデルにおけるFMISOによる腫瘍内酸素状態の評価2013

    • Author(s)
      于 聞文、趙 松吉、村上 正紘、趙 芫、ファティマ チョウドリヌスッラト、西嶋 剣一、北川 善政、玉木 長良、久下 裕司
    • Organizer
      第53回日本核医学学術総会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET reflects antiangiogenic tumor response after sorafenib treatment in human renal cell carcinoma xenograft2013

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Organizer
      The 60^<th> Society of Nuclear Medicine and Molecular Imaging Annual Meeting
    • Place of Presentation
      Vancouver
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 抗血管新生剤(sorafenib)の抗腫瘍効果の機序:肺癌細胞移植モデルにおけるFMISOによる腫瘍内酸素状態の評価2013

    • Author(s)
      于聞文、趙松吉、村上正紘、趙芫、ファティマチョウドリヌスッラト、西嶋剣一、北川善政、玉木長良、久下裕司
    • Organizer
      第53回日本核医学学術総会
    • Place of Presentation
      福岡市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET reflects antiangiogenic tumor response after sorafenib treatment in human renal cell carcinoma xenograft2013

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Organizer
      The 60th Society of Nuclear Medicine and Molecular Imaging Annual Meeting
    • Place of Presentation
      Vancouver Convention Center (Vancouver, Canada)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 腎細胞癌移植モデルにおける抗血管新生剤(sorafenib)の治療反応のFMISO PETによる評価2013

    • Author(s)
      趙 松吉、于 聞文、村上 正紘、趙 芫、ファティマ チョウドリ ヌスラット、西嶋 剣一、右近 直之、久保 直樹、玉木 長良、久下 裕司
    • Organizer
      第53回日本核医学学術総会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 18F-FLT can predict tumor proliferation response to radiotherapy in human head and neck cancer xenograft in comparison with Ki-672013

    • Author(s)
      Chowdhury NF, Zhao S, Zhao Y, Murakami M, Yu W, Nishijima K, Tamaki N, Kitagawa Y, Kuge Y
    • Organizer
      日本薬学会第133回年会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] Preparation and evaluation of [^<123>I]IIMU for SPECT imaging of thymidine phosphorylase expression in tumors2013

    • Author(s)
      Nishijima K, Zhao S, Zhao Y, Feng F, Shimizu Y, Abo N, Akizawa H, Ohkura K, Tamaki N, Kuge Y
    • Organizer
      The 20^<th> International Symposium on Radiopharmaceutical Sciences
    • Place of Presentation
      Jeju, Korea
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] Preparation and evaluation of [123I]IIMU for SPECT imaging of thymidine phosphorylase expression in tumors2013

    • Author(s)
      Nishijima K, Zhao S, Zhao Y, Feng F, Shimizu Y, Abo N, Akizawa H, Ohkura K, Tamaki N, Kuge Y
    • Organizer
      The 20th International Symposium on Radiopharmaceutical Sciences
    • Place of Presentation
      Jeju International Convention Center (Jeju, Korea)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] Sequential evaluation of intratumoral proliferative activity after radiotherapy by FLT in human head and neck cancer xenograft2013

    • Author(s)
      Fatema CN, Zhao S, Zhao Y, Murakami M, Yu W, Nishijima K, Kitagawa Y, Tamaki N, Kuge Y
    • Organizer
      The 60th Society of Nuclear Medicine and Molecular Imaging Annual Meeting
    • Place of Presentation
      Vancouver Convention Center (Vancouver, Canada)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 腎細胞癌移植モデルにおける抗血管新生剤(sorafenib)の治療反応のFMISO PETによる評価2013

    • Author(s)
      趙松吉、于聞文、村上正紘、趙芫、ファティマチョウドリヌスラット、西嶋剣一、右近直之、久保直樹、玉木長良、久下裕司
    • Organizer
      第53回日本核医学学術総会
    • Place of Presentation
      福岡市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FLT can early reflect response of tumor proliferation to multikinase inhibitor (sorafenib) treatment in a human renal cell carcinoma xenograft : comparison with Ki-672012

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Organizer
      The 2012 World Molecular Imaging Congress
    • Place of Presentation
      Dublin, Ireland
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] チミジンホスホリラーゼを標的とする新規腫瘍イメージング剤(123I-IIMU)の開発:マウス組織におけるチミジンホスホリラーゼ発現と123I-IIMU集積との関係。2012

    • Author(s)
      趙松吉、李花、西嶋剣一、秋澤宏行、大倉一枝、玉木長良、久下裕司
    • Organizer
      第7回日本分子イメージング学会総会・学術集会
    • Place of Presentation
      アクトシティ浜松(浜松市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 特別講演1.癌の診断・治療効果評価におけるPETの応用~基礎研究を中心に~ 口腔顔面核医学フォーラム20122012

    • Author(s)
      趙松吉、久下裕司、玉木長良
    • Organizer
      第52回日本核医学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 腫瘍・肉芽腫における18F-FMISO集積の特徴:18F-FDG及び組織学的比較2012

    • Author(s)
      趙松吉、伊敏、趙芫、西嶋剣一、村上正紘、于聞文、チョウドリ ヌスラット ファティマ、孫田恵、小華和柾志、玉木長良、久下裕司
    • Organizer
      第52回日本核医学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET reflects antiangiogenic tumor response to multi-kinase inhibitor (sorafenib) in human renal cell carcinoma xenograft2012

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Nusrat C, Yu W, Nishijima K, Takiguchi T, Tamaki N, Kuge Y
    • Organizer
      The 59th Annual Meeting, Society of Nuclear Medicine
    • Place of Presentation
      the Miami Beach Convention Center (Miami, US)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] チミジンホスホリラーゼイメージング剤[^<123>I]5-iodo-6-[(2-iminoimidazolidiny l)methyl]uracilの開発:タンパク結合測定と画像化の検討2012

    • Author(s)
      西嶋剣一、越田早織、趙松吉、秋澤宏行、大倉一枝、松本博樹、志賀哲、玉木長良、久下裕司
    • Organizer
      日本薬学会第132回年会
    • Place of Presentation
      札幌市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 18F-fluorodeoxyglucose uptake reflects thrombus formation and tissue factor expression via nuclear factor-kB in rabbit atherosclerotic lesions2012

    • Author(s)
      Atsushi Yamashita, Yan Zhao, Yunosuke Matsuura, Kazuaki Yamasaki Chihiro Sugita, Keiichi Kawai, Nagara Tamaki, Songji Zhao, Yuji Kuge, Yujiro Asada
    • Organizer
      American Heart Association Scientific Sessions 2012
    • Place of Presentation
      Los Angeles Convention Center, Los Angeles, CA, U.S.A
    • Data Source
      KAKENHI-PROJECT-23659573
  • [Presentation] 動脈血栓能を反映する18F-フルオロデオキシグルコースの血管集積2012

    • Author(s)
      山下篤、趙芫、趙松吉、松浦祐之介、川井恵一、玉木長良、久下裕司、浅田祐士郎
    • Organizer
      第52回日本核医学会学術総会。
    • Place of Presentation
      ロイトン札幌
    • Data Source
      KAKENHI-PROJECT-23659573
  • [Presentation] チミジンホスホリラーゼを標的とする新規腫瘍イメージング剤(^<123>I-IIMU)の開発:マウス組織におけるチミジンホスホリラーゼ発現と^<123>I-IIMU集積との関係2012

    • Author(s)
      趙松吉、李花、西嶋剣一、秋澤宏行、大倉一枝、玉木長良、久下裕司
    • Organizer
      日本分子イメージング学会第7回総会・学術集会
    • Place of Presentation
      浜松市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 腎細胞癌移植マウスにおけるマルチキナーゼ阻害剤Sorafenib治療後のFLTによる治療反応評価2012

    • Author(s)
      村上正紘、趙松吉、趙芫、マチョウドリヌスラットファティ、于聞文、西嶋剣一、久保直樹、滝口満喜、玉木長良、久下裕司
    • Organizer
      第52回日本核医学学術総会
    • Place of Presentation
      札幌市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FLT can early reflect response of tumor proliferation to multikinase inhibitor (sorafenib) treatment in a human renal cell carcinoma xenograft: comparison with Ki-672012

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Nusrat C, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Organizer
      The 2012 World Molecular Imaging Congress
    • Place of Presentation
      The Convention Centre (Dublin, Ireland)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] ^<18>F-FMISOを用いた腎細胞癌移植モデルにおける抗血管新生療法(sorafenib)の早期治療反応の評価2012

    • Author(s)
      村上正紘、趙松吉、趙芫、チョウドリヌスラットファティマ、于聞文、西嶋剣一、滝口満喜、玉木長良、久下裕司
    • Organizer
      日本分子イメージング学会第7回総会・学術集会
    • Place of Presentation
      浜松市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET reflects antiangiogenic tumor response to multi-kinase inhibitor (sorafenib) in human renal cell carcinoma xenograft2012

    • Author(s)
      Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
    • Organizer
      The 59^<th> Society of Nuclear Medicine Annual Meeting
    • Place of Presentation
      Miami
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] チミジンホスホリラーゼイメージング剤[123I]5-iodo-6-[(2-iminoimidazolidinyl)methyl]uracilの開発:タンパク結合測定と画像化の検討2012

    • Author(s)
      西嶋剣一、越田早織、趙松吉、秋澤宏行、大倉一枝、松本博樹、志賀 哲、玉木長良、久下裕司
    • Organizer
      日本薬学会 第132年会
    • Place of Presentation
      北海道大学(札幌)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] ^<18>F-Fluorothymidine (18F-FLT) as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft2011

    • Author(s)
      Takeuchi S, Zhao S, Kuge Y, Zhao Y, Nishijima K, Shimizu Y, Kinoshita I, Tamaki N, Dosaka-Akita H
    • Organizer
      The 14^<th> World Conference on Lung Cancer
    • Place of Presentation
      Amsterdam
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] ヒト癌移植マウスにおける抗EGFR抗体(Cetuximab)による分子標的療法:18F-FMISOを用いた早期治療効果評価。2011

    • Author(s)
      趙 松吉、久下 裕司、趙 芫、竹内 啓、村上 正紘、李 花、チョウドリヌスラット ファティマ、西嶋 剣一、竹井 俊樹、秋田 弘俊、玉木 長良。
    • Organizer
      第51回日本核医学会学術総会
    • Place of Presentation
      つくば国際会議場(茨城)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] ヒト癌移植マウスにおける抗EGFR抗体(Cetuximab)による分子標的療法:^<18>F-FMISOを用いた早期治療効果評価2011

    • Author(s)
      趙松吉、久下裕司、趙芫、竹内啓、村上正紘、李花、チョウドリヌスラットファティマ、西嶋剣一、竹井俊樹、秋田弘俊、玉木長良
    • Organizer
      第51回日本核医学会学術総会
    • Place of Presentation
      つくば市
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET can early evaluate antiangiogenic response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.2011

    • Author(s)
      Zhao S, Kuge Y, Zhao Y, Takeuchi S, Murakami M, Li H, Nusrat F Chouwdhury, Nishijima K, Dosaka-Akita H, Tamaki N.
    • Organizer
      The 58th Annual Meeting, Society of Nuclear Medicine
    • Place of Presentation
      The H.B. Gonzalez Convention Center (USA)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] 18F-Fluorothymidine PET/CT as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.2011

    • Author(s)
      Takeuchi S, Zhao S, Kuge Y, Zhao Y, Nishijima K, Shimizu Y, Kinoshita I, Tamaki N and Dosaka-Akita H.
    • Organizer
      The AACR 102nd Annual Meeting
    • Place of Presentation
      The Orange County Convention Center (USA)
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] FMISO PET can early evaluate antiangiogenic response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft2011

    • Author(s)
      Zhao S, Kuge Y, Zhao Y, Takeuchi S, Murakami M, Li H, Nusrat C, Nishijima K, Dosaka-Akita H, Tamaki N
    • Organizer
      The 58^<th> Society of Nuclear Medicine Annual Meeting
    • Place of Presentation
      San Antonio
    • Data Source
      KAKENHI-PROJECT-23591742
  • [Presentation] Evaluation of intratumoral ^<18>F-FDG distribution using small animal PET : Comparison with autoradiography2010

    • Author(s)
      S.Zhao, et al.
    • Organizer
      2010 World Molecular Imaging Congress
    • Place of Presentation
      Kyoto, Japan.(国立京都国際会館)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] A novel radiolabeled probe for molecular imaging of thymidine phosphorylase : Suppressed accumulation into tumor cells by target gene knockdown.2010

    • Author(s)
      Li H, Zhao S, Jin Y, Nishijima K, Akizawa H, Ohkura K, Seki K, Tamaki N, Kuge Y
    • Organizer
      2010 World Molecular Imaging Congress
    • Place of Presentation
      Kyoto, Japan.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Hyoxia imaging with ^<18>F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas : A comparison with FDG in experimental rat models using small animal PET2010

    • Author(s)
      S.Zhao, et al.
    • Organizer
      57th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Salt Lake City, Utah (America)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] ヒト癌移植マウスにおける抗EGFR抗体(Cetuximab)による分子標的療法:^<18>F-FLT-PETを用いた早期治療効果評価2010

    • Author(s)
      趙松吉, 他
    • Organizer
      第5回日本分子イメージング学会学術集会
    • Place of Presentation
      滋賀県大津(ピアザ淡海滋賀県民交流センター)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] 肉芽腫・腫瘍における^<18>F-FMISO-PETの有用性:小動物用PETを用いた基礎的検討2010

    • Author(s)
      趙松吉, 他
    • Organizer
      第50回日本核医学会総会
    • Place of Presentation
      さいたま(大宮ソニックシティ)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Hyoxia imaging with ^<18>F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas : A comparison with FDG in experimental rat models using small animal PET.2010

    • Author(s)
      Zhao S, Kuge Y, Zhao Y, Yi M, Hatano T, Suzuki K, Magota K, Nishijima K, Kohanawa M, Tamaki N
    • Organizer
      57th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Salt Lake City.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Biologic aspects of intratumoral [^<18>F]FMISO distribution in a rodent model of glioma.2010

    • Author(s)
      Hatano T, Zhao S, Zhao Y, Nishijima K, Kuno K, Hanzawa H, Sakamoto T, Tamaki N, Kuge Y
    • Organizer
      57th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Salt Lake City.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] FLT PET can early predict antiproliferative response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft2010

    • Author(s)
      S.Zhao, et al.
    • Organizer
      57th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Salt Lake City, Utah (America)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] FLT PET can early predict antiproliferative response to anti-EGFR moleculartargeting therapy (cetuximab) in human lung cancer xenograft.2010

    • Author(s)
      Zhao S, Takeuchi S, Kuge Y, Zhao Y, Hatano T, Li H, Nishijima K, Kinoshita I, Dosaka-Akita H, Tamaki N
    • Organizer
      57th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Salt Lake City.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] 肉芽腫・腫瘍の鑑別診断におけるdynamic C-MET-PETの有用性:小動物PETを用いた基礎的検討。2009

    • Author(s)
      趙松吉, 他
    • Organizer
      第49回日本核医学会総会
    • Place of Presentation
      旭川(旭川市民文化会館、旭川グランドホテル)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy(bevacizumab)in human tumor xenograft using FLT.2009

    • Author(s)
      Zhao S, et al.
    • Organizer
      56th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Toronto, Canada
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Dynamic MET PET analysis has an additional value for differentiating tumors from granulomas : An experimental study using small animal PET.2009

    • Author(s)
      Zhao S, et al.
    • Organizer
      56th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Toronto, Canada
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] ヒト癌細胞移植マウスにおける抗VEGF抗体(Bevacizumab)による分子標的療法;FLTを用いた早期治療効果評価。2009

    • Author(s)
      趙松吉, 他
    • Organizer
      第49回日本核医学会総会
    • Place of Presentation
      旭川(旭川市民文化会館、旭川グランドホテル)
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT.2009

    • Author(s)
      Zhao S, Kuge Y, Zhao Y, Takeuchi S, Jin Y, Hatano T, Kinoshita I, Dosaka-Akita H, Tamaki N
    • Organizer
      56th Annual Meeting of the Society of Nuclear Medicine
    • Place of Presentation
      Tronto.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Dynamics of 18F-FDG Uptake in Experimental Granuloma and Tumor: Basic Studies in Rat Models Using Small Animal PET / CT System2008

    • Author(s)
      Zhao S, et.al.
    • Organizer
      2008 World Molecular Imaging Congress
    • Place of Presentation
      Nice, The Acropolis Convention Center
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Synthesis of a Potential SPECT Tracer for Angiogenic Enzyme Expression Graduate School of Medicine.2008

    • Author(s)
      Seki K, Takahashi M, Zhao S, Nishijima K, Kuge Y, Tamaki N, Ohkura K
    • Organizer
      2008 World Molecular Imaging Congress
    • Place of Presentation
      Nice.
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Rhodococcus肉芽腫とラットglioma腫瘍ラットモデルにおけるFDG集積の比較検討2008

    • Author(s)
      趙松吉, 他
    • Organizer
      第49回日本核医学会総会
    • Place of Presentation
      千葉、幕張メッセ
    • Data Source
      KAKENHI-PROJECT-20390320
  • [Presentation] Preclinical evaluation of thymidine phosphorylase imaging probe, 123I-IIMU for the First-in-Human clinical trials.

    • Author(s)
      Nishijima K, Zhao S, Feng F, Shimizu Y, Akizawa H, Ohkura K, Kobashi N. Abe T, Matsumoto H, Tamaki N, Kuge Y
    • Organizer
      The 12th International Symposium for Future Drug Discovery and Medical Care, Perspectives of Molecular and Target Therapy
    • Place of Presentation
      Sapporo
    • Year and Date
      2014-09-04 – 2014-09-05
    • Data Source
      KAKENHI-PROJECT-26461802
  • 1.  KUGE Yuji (70321958)
    # of Collaborated Projects: 12 results
    # of Collaborated Products: 70 results
  • 2.  NISHIJIMA Ken=ichi (60364254)
    # of Collaborated Projects: 11 results
    # of Collaborated Products: 92 results
  • 3.  Oriuchi Noboru (40292586)
    # of Collaborated Projects: 7 results
    # of Collaborated Products: 45 results
  • 4.  高橋 和弘 (20370257)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 47 results
  • 5.  右近 直之 (70792985)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 60 results
  • 6.  OHKURA Kazue (60094827)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 8 results
  • 7.  SHIGA Tohru (80374495)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 6 results
  • 8.  AKIZAWA Hiromichi (90311795)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 3 results
  • 9.  Washiyama Kohshin (80313675)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 40 results
  • 10.  SHIMIZU Youichi (90634212)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 6 results
  • 11.  YAMASHITA Atsushi (90372797)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 4 results
  • 12.  粟生木 美穂 (10783227)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 48 results
  • 13.  杉山 暁 (40562715)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 21 results
  • 14.  池添 隆之 (80294833)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 5 results
  • 15.  KAWAI Keiichi (30204663)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 16.  KITAGAWA Yoshimasa (00224957)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 17.  東川 桂 (10756878)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 18.  水野 雄貴 (90805194)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 19.  YOSHINAGA Keiichiro (30435961)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  TAMAKI Nagara (30171888)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 13 results
  • 21.  SEKI KohーIchi (60094835)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 22.  TAKEI Toshiki (60374493)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 23.  河嶋 秀和 (70359438)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 24.  久保 均 (00325292)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 25.  大島 康宏 (00588676)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 26.  石岡 典子 (30354963)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 27.  富永 英之 (00393348)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 28.  安井 博宣 (10570228)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 29.  竹内 啓 (30374515)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 30.  宿里 充穗 (20525571)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 31.  尾江 悟 (90756107)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 32.  阿部 悠 (00722472)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 33.  長谷川 有史 (70404879)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 34.  伊藤 浩 (20360357)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 17 results
  • 35.  竹内 康人 (10735187)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 36.  大賀 則孝 (40548202)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 37.  佐藤 淳 (60319069)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 38.  犬伏 正幸 (70399830)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 39.  山下 雄史 (50615622)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 40.  横山 明彦 (80230655)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 41.  巽 俊文 (80868232)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 16 results
  • 42.  川村 文彦 (10757074)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 43.  小山 大輔 (50741071)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 44.  南 陽介 (60513752)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 45.  立花 太郎 (80311752)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 46.  鬼頭 勇輔 (80444305)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 47.  崔 正国 (90572115)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 48.  関亦 明子 (50321823)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 49.  小島 祥敬 (60305539)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 50.  岡本 祥三 (20431364)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 51.  SHIMOMURA Kenju
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 52.  KITAMURA Yoji
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 53.  鈴木 弘行
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 54.  大野 雄康
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi